You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / MANGALAM DRUGS & ORGANICS

MANGALAM DRUGS & ORGANICS
Intrinsic Value | Fundamental Analysis

Returns | 1W : -3.1% , 1M : -2.3%,1Y : 145.3%
BOM : 532637     NSE : MANGALAM    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Good [Stock is Cheap]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : Average [>25% and <50%]
Apr 19,2021
Price(EOD): Rs. 106.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 168.51 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
MANGALAM DRUGS & ORGANICS -3.1% -2.3% 145.3%
SUN PHARMACEUTICAL INDUSTRIES 3.4% 6.4% 39.2%
DR REDDYS LABORATORIES -0.4% 11.7% 26.7%
DIVIS LABORATORIES 0.6% 12.6% 59.7%
CIPLA 4.8% 19.4% 56.3%
BIOCON 0.6% 3.5% 18%
AUROBINDO PHARMA 5.4% 14.8% 74.8%
LUPIN 1.5% 0.6% 27.8%
TORRENT PHARMACEUTICALS 1.6% 5% 12.5%

FUNDAMENTAL ANALYSIS OF MANGALAM DRUGS & ORGANICS

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than MANGALAM DRUGS & ORGANICS Premium


VALUATION OF MANGALAM DRUGS & ORGANICS

 
Valuation Score
RatioValue
P/E
P/B
P/S
20.47
P/E Calculated based on EPS of 5.21
[ Mar2020 - Standalone Results ]

1.62
P/B Calculated based on Book Value of 65.67
[ Mar2020 - Standalone Results ]

0.53
P/S Calculated based on Revenues of 320.953 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than MANGALAM DRUGS & ORGANICS Premium


FAIR VALUE OF MANGALAM DRUGS & ORGANICS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
29%
-22%
-23%

SHARE PRICE MOMENTUM OF MANGALAM DRUGS & ORGANICS

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.48
0.66
0.66
0.6
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
33.57 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
-8.59%
-24.22%
-31.61%
-41.97%
43.17%
146.89%
805.22%
289.64%
QtrlyTrend
0
Latest Qtr: Dec2020

MANGALAM DRUGS & ORGANICS related INDICES

No BSE index found!
No NSE index found

FAQ [Frequently Asked Questions]


Is MANGALAM good for long term investment?

As on 19-Apr-2021, the Fundamentals of MANGALAM are Poor and hence it's not good for long term investment ! See Financial Performance of MANGALAM DRUGS & ORGANICS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is MANGALAM UnderValued or OverValued?

As on 19-Apr-2021, MANGALAM is Under Valued and hence a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of MANGALAM ?

As on 19-Apr-2021, the Intrinsic Value of MANGALAM is Rs. 136.08 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 82.92
Fair Value [Median EV / Sales Model] : Rs. 136.08
Fair Value [Median Price / Sales Model] : Rs. 137.81
Median Fair Value of MANGALAM : Rs. 136.08

Is MANGALAM trading at a Premium or Discount?

As on 19-Apr-2021, MANGALAM is trading at a Discount of -22% based on the Median Intrinsic Value!

Is it right time to buy MANGALAM shares?

As on 19-Apr-2021, MANGALAM is Under Valued and hence a good buying opportunity according to Share Valuation at this time!
One can wait for the Share Price Momentum to become bullish before entering the stock!

What is the Financial Performance of Industry Peers of MANGALAM?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with MANGALAM?

MANGALAM DRUGS & ORGANICS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
MANGALAM DRUGS & ORGANICS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
MANGALAM DRUGS & ORGANICS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
MANGALAM DRUGS & ORGANICS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
MANGALAM DRUGS & ORGANICS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
MANGALAM DRUGS & ORGANICS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
MANGALAM DRUGS & ORGANICS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
MANGALAM DRUGS & ORGANICS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
MANGALAM DRUGS & ORGANICS LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z